Technical Analysis for TCBP - TC BioPharm (Holdings) plc

Grade Last Price % Change Price Change
D 0.953 -6.57% -0.07
TCBP closed down 6.57 percent on Monday, May 16, 2022, on 6 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -6.57%
Gapped Up Strength -6.57%
Oversold Stochastic Weakness -6.57%
Stochastic Reached Oversold Weakness 0.32%
Strong but Oversold Other 0.32%
Wide Bands Range Expansion 0.32%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 8 hours ago
60 Minute Opening Range Breakdown about 10 hours ago
Lower Bollinger Band Support about 10 hours ago
Down 5% about 11 hours ago
Down 3% about 11 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Solid Tumors Immune System Immunotherapy Cancer Treatment Cancer Immunotherapy Cell Biology Acute Myeloid Leukemia Cell Therapy Treatment Of Acute Myeloid Leukemia Immunotherapy Products T Cells

Is TCBP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 3.5
52 Week Low 0.88
Average Volume 1,442,986
200-Day Moving Average 0.00
50-Day Moving Average 1.26
20-Day Moving Average 1.24
10-Day Moving Average 1.22
Average True Range 0.20
RSI 38.27
ADX 20.28
+DI 16.54
-DI 19.77
Chandelier Exit (Long, 3 ATRs) 0.97
Chandelier Exit (Short, 3 ATRs) 1.53
Upper Bollinger Bands 1.56
Lower Bollinger Band 0.91
Percent B (%b) 0.07
BandWidth 52.68
MACD Line -0.07
MACD Signal Line -0.03
MACD Histogram -0.0431
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.12
Resistance 3 (R3) 1.14 1.10 1.09
Resistance 2 (R2) 1.10 1.06 1.09 1.08
Resistance 1 (R1) 1.03 1.03 1.01 1.01 1.07
Pivot Point 0.99 0.99 0.98 0.98 0.99
Support 1 (S1) 0.92 0.95 0.90 0.90 0.83
Support 2 (S2) 0.88 0.92 0.87 0.82
Support 3 (S3) 0.81 0.88 0.82
Support 4 (S4) 0.79